Compagnie Lombard Odier SCmA’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,000
| Closed | -$18.5K | – | 689 |
|
2023
Q3 | $18.5K | Hold |
1,000
| – | – | ﹤0.01% | 491 |
|
2023
Q2 | $11.1K | Hold |
1,000
| – | – | ﹤0.01% | 498 |
|
2023
Q1 | $13.4K | Hold |
1,000
| – | – | ﹤0.01% | 540 |
|
2022
Q4 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 594 |
|
2022
Q3 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 552 |
|
2022
Q2 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 526 |
|
2022
Q1 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 529 |
|
2021
Q4 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 599 |
|
2021
Q3 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 576 |
|
2021
Q2 | $20K | Hold |
1,000
| – | – | ﹤0.01% | 553 |
|
2021
Q1 | $23K | Hold |
1,000
| – | – | ﹤0.01% | 562 |
|
2020
Q4 | $25K | Hold |
1,000
| – | – | ﹤0.01% | 487 |
|
2020
Q3 | $41K | Hold |
1,000
| – | – | ﹤0.01% | 390 |
|
2020
Q2 | $48K | Hold |
1,000
| – | – | ﹤0.01% | 370 |
|
2020
Q1 | $63K | Hold |
1,000
| – | – | ﹤0.01% | 335 |
|
2019
Q4 | $124K | Hold |
1,000
| – | – | ﹤0.01% | 289 |
|
2019
Q3 | $66K | Hold |
1,000
| – | – | ﹤0.01% | 339 |
|
2019
Q2 | $80K | Buy |
+1,000
| New | +$80K | ﹤0.01% | 324 |
|
2017
Q4 | – | Sell |
-1,549
| Closed | -$90K | – | 711 |
|
2017
Q3 | $90K | Buy |
+1,549
| New | +$90K | ﹤0.01% | 444 |
|
2017
Q2 | – | Sell |
-1,759
| Closed | -$199K | – | 754 |
|
2017
Q1 | $199K | Buy |
+1,759
| New | +$199K | 0.01% | 368 |
|
2016
Q3 | – | Sell |
-2,436
| Closed | -$348K | – | 929 |
|
2016
Q2 | $348K | Sell |
2,436
-1,151
| -32% | -$164K | 0.01% | 400 |
|
2016
Q1 | $461K | Buy |
+3,587
| New | +$461K | 0.01% | 349 |
|
2015
Q2 | – | Sell |
-40
| Closed | -$11K | – | 950 |
|
2015
Q1 | $11K | Hold |
40
| – | – | ﹤0.01% | 895 |
|
2014
Q4 | $6K | Buy |
+40
| New | +$6K | ﹤0.01% | 734 |
|